iomeprol has been researched along with Anemia, Hemolytic in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurin, C | 1 |
| Vassal, O | 1 |
| Darien, M | 1 |
| Raba, M | 1 |
| Allaouchiche, B | 1 |
| Piriou, V | 1 |
1 review available for iomeprol and Anemia, Hemolytic
| Article | Year |
|---|---|
Immune hemolysis secondary to injection of contrast medium.
Topics: Adult; Anemia, Hemolytic; Antibody Specificity; Catecholamines; Combined Modality Therapy; Contrast | 2018 |